Found "Public health policy": 1,132 results
Key Recommendations: Strengthening Public Health Capacity and Fostering Regional Solidarity
The COVID-19 pandemic revealed global healthcare system vulnerabilities and societal impacts (1). Many countries experienced disruptions in health service delivery, exacerbating challenges in essential health services, human resources, and medical supply allocation (2, 3). As such, enhanced capabili
Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower- Middle Income Country? A Cost-Utility Analysis in the Philippines (2015)
Manuel Alexander Haasis1*, Joyce Anne Ceria1, Wantanee Kulpeng2,
Yot Teerawattananon2, Marissa Alejandria3
1 National Center for Pharmaceutical Access and Management (NCPAM), Department of Health, Manila,
Philippines, 2 Health Intervention and Technology Assessment Program (HITAP), Department of
Hospitals named and shamed over drug access
Patients in England will soon be able to see if their local health authority is offering the latest approved drugs and treatments, as scorecards rating hospitals become public.The scheme, to be rolled out before autumn, aims to create a level playing field for treatments such as IVF.Authorities foun
Mercury, oils from fish at odds in heart health
(Reuters Health) – Mercury and omega-3 fatty acids – both found in fish – appear to have opposite links to heart health, scientists have found.In an analysis of more than 1,600 men from Sweden and Finland, researchers found that men with high levels of mercury in the body had an increased risk of he
Funding cuts imperil European fight against TB, HIV
(Reuters) – Cuts in global funding for Eastern Europe and Central Asia are undermining the fight against tuberculosis (TB) and the AIDS virus, threatening to push already high rates of disease and drug-resistance even higher, experts said on Wednesday.In a report by leading European non-governmental
Rapid Health Technology Assessment: A Cost-Utility and Budget Impact Analysis of Abiraterone Acetate for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) After Docetaxel Therapy
Management of advanced prostate cancer, particularly in cases of metastatic castration-resistant prostate cancer (mCRPC), typically involves first-line treatment with the chemotherapeutic agent docetaxel. Nevertheless, disease progression following docetaxel therapy remains a major challenge, as there are currently no therapeutic options listed in
Health Technology Assessment Development in Lao PDR
Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi
Conducive Factors to the Development of Health Technology Assessment
With Universal Health Coverage (UHC) high on the global health agenda, governments of many low- and middle-income countries (LMICs) have pledged to increase health investments in the scale-up of essential health services to meet the needs of their people. This has led to the recognition of hea
EVIDENCE APPRAISAL WORKSHOP FOR PHILIPPINE HTA COUNCIL
In the Philippines, use of HTA is not completely new; there have been prior efforts to institutionalize a fair and systematic process of generating policy-relevant evidence to inform coverage of health services, such as listing of drugs in the national formulary and new benefits in the national soci
Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience
Abstract
India’s rapid economic growth has been accompanied by slower improvements in population health. Given the need to reconcile the ambitious goal of achieving Universal Coverage with limited resources, a robust priority-setting mechanism is required to ensure that the right trade-offs arema
10 / Page